377 related articles for article (PubMed ID: 35092121)
21. PRKCZ-AS1 promotes the tumorigenesis of lung adenocarcinoma via sponging miR-766-5p to modulate MAPK1.
Wang M; Liao Q; Zou P
Cancer Biol Ther; 2020 Apr; 21(4):364-371. PubMed ID: 31939714
[TBL] [Abstract][Full Text] [Related]
22. miR-9-5p Promotes Lung Adenocarcinoma Cell Proliferation, Migration and Invasion by Targeting ID4.
Zhu K; Lin J; Chen S; Xu Q
Technol Cancer Res Treat; 2021; 20():15330338211048592. PubMed ID: 34723712
[No Abstract] [Full Text] [Related]
23. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
[TBL] [Abstract][Full Text] [Related]
24. LINC00324 exerts tumor-promoting functions in lung adenocarcinoma via targeting miR-615-5p/AKT1 axis.
Pan ZH; Guo XQ; Shan J; Luo SX
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8333-8342. PubMed ID: 30556874
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial cell-derived exosomal miR-30a-5p inhibits lung adenocarcinoma malignant progression by targeting CCNE2.
Tao K; Liu J; Liang J; Xu X; Xu L; Mao W
Carcinogenesis; 2021 Aug; 42(8):1056-1067. PubMed ID: 34128973
[TBL] [Abstract][Full Text] [Related]
26. HCG18/miR-34a-5p/HMMR axis accelerates the progression of lung adenocarcinoma.
Li W; Pan T; Jiang W; Zhao H
Biomed Pharmacother; 2020 Sep; 129():110217. PubMed ID: 32559619
[TBL] [Abstract][Full Text] [Related]
27. miR-30a-5p Regulates Viability, Migration, and Invasion of Lung Adenocarcinoma Cells via Targeting ECT2.
Chen S; Zhu X; Zheng J; Xu T; Xu Y; Chen F
Comput Math Methods Med; 2021; 2021():6241469. PubMed ID: 34306175
[TBL] [Abstract][Full Text] [Related]
28. LINC00942 Promotes Tumor Proliferation and Metastasis in Lung Adenocarcinoma via FZD1 Upregulation.
Wang R; Wang X; Zhang J; Liu Y
Technol Cancer Res Treat; 2021; 20():1533033820977526. PubMed ID: 34253104
[TBL] [Abstract][Full Text] [Related]
29. LncRNA-LINC01089 inhibits lung adenocarcinoma cell proliferation and promotes apoptosis via sponging miR-543.
Xu Y; Lin L; Lv D; Yan S; He S; Ge H
Tissue Cell; 2021 Oct; 72():101535. PubMed ID: 33892399
[TBL] [Abstract][Full Text] [Related]
30. Cancer-derived exosomal miR-197-3p confers angiogenesis via targeting TIMP2/3 in lung adenocarcinoma metastasis.
Chang RM; Fu Y; Zeng J; Zhu XY; Gao Y
Cell Death Dis; 2022 Dec; 13(12):1032. PubMed ID: 36494333
[TBL] [Abstract][Full Text] [Related]
31. Tumor-suppressive action of miR-30a-5p in lung adenocarcinoma correlates with ABL2 inhibition and PI3K/AKT pathway inactivation.
Miao Y; Liu J
Clin Transl Oncol; 2024 Feb; 26(2):398-413. PubMed ID: 37479901
[TBL] [Abstract][Full Text] [Related]
32. Serum exosomal miR-16-5p functions as a tumor inhibitor and a new biomarker for PD-L1 inhibitor-dependent immunotherapy in lung adenocarcinoma by regulating PD-L1 expression.
Chen HL; Luo YP; Lin MW; Peng XX; Liu ML; Wang YC; Li SJ; Yang DH; Yang ZX
Cancer Med; 2022 Jul; 11(13):2627-2643. PubMed ID: 35347894
[TBL] [Abstract][Full Text] [Related]
33. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.
Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H
Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387
[TBL] [Abstract][Full Text] [Related]
34. LINC00968 can inhibit the progression of lung adenocarcinoma through the miR-21-5p/SMAD7 signal axis.
Zhu Y; Bo H; Chen Z; Li J; He D; Xiao M; Xiang L; Jin L; Zhou J; Gong L; Zhou Y; Zhou M; Xiong W; Xing X; Li R; Cao K
Aging (Albany NY); 2020 Nov; 12(21):21904-21922. PubMed ID: 33147570
[TBL] [Abstract][Full Text] [Related]
35. MiR-485-5p Suppress the Malignant Characteristics of the Lung Adenocarcinoma via Targeting NADPH Quinone Oxidoreductase-1 to Inhibit the PI3K/Akt.
Chen Y; Wu L; Bao M
Mol Biotechnol; 2023 May; 65(5):794-806. PubMed ID: 36219369
[TBL] [Abstract][Full Text] [Related]
36. MiR-340-3p-HUS1 axis suppresses proliferation and migration in lung adenocarcinoma cells.
Ren K; Yu Y; Wang X; Liu H; Zhao J
Life Sci; 2021 Jun; 274():119330. PubMed ID: 33711383
[TBL] [Abstract][Full Text] [Related]
37. Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7/CEP55.
Fu L; Li Z; Wu Y; Zhu T; Ma Z; Dong L; Ding J; Zhang C; Yu G
Biochem Genet; 2023 Aug; 61(4):1528-1547. PubMed ID: 36658310
[TBL] [Abstract][Full Text] [Related]
38. miR-31-5p modulates cell progression in lung adenocarcinoma through TNS1/p53 axis.
Zhu C; Wang S; Zheng M; Chen Z; Wang G; Ma J; Zhang B; Huang W; Sun X; Wang C
Strahlenther Onkol; 2022 Mar; 198(3):304-314. PubMed ID: 35037949
[TBL] [Abstract][Full Text] [Related]
39. M2 macrophage-derived exosomes promote lung adenocarcinoma progression by delivering miR-942.
Wei K; Ma Z; Yang F; Zhao X; Jiang W; Pan C; Li Z; Pan X; He Z; Xu J; Wu W; Xia Y; Chen L
Cancer Lett; 2022 Feb; 526():205-216. PubMed ID: 34838826
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-365 inhibits the progression of lung adenocarcinoma through targeting ETS1 and inactivating AKT/mTOR pathway.
Tong L; Han WZ; Wang JL; Sun NN; Zhuang M
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4836-4845. PubMed ID: 32432746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
